New research identifies which countries may be better positioned to accept a ‘new normal’ of living with COVID-19
SARS-CoV-2 mimics could accelerate vaccine research, make it safer
21 September 2022Research reveals potential targets for therapeutic development for glioblastoma
21 September 2022New research identifies which countries may be better positioned to accept a ‘new normal’ of living with COVID-19
With the eradication of COVID-19 out of reach, are we close to a “new normal” in which we can leave restrictive non-pharmaceutical interventions (NPIs) behind—such as masks and social distancing—while simultaneously limiting the burden of disease and deaths? According to researchers at MIT Sloan School of Management, the answer depends on the ongoing risks versus communities’ tolerance for those risks.
